Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial

NCT06778408 is registered in ClinicalTrials.gov with University of Vermont Medical Center as lead sponsor.

NCT NCT06778408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06778408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial
Lead sponsor
University of Vermont Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
April 28, 2025
Completion date
March 31, 2028
Enrollment
103 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer (different solid tumour types), palliative radiotherapy